Currently out of the existing stock ratings of Vernon Bernardino, 236 are a BUY (94.78%), 13 are a HOLD (5.22%).

Vernon Bernardino

Work Performance Price Targets & Ratings Chart

Analyst Vernon Bernardino, carries an average stock price target met ratio of 47.34% that have a potential upside of 63.16% achieved within 407 days. Previously, Vernon Bernardino worked at B. RILEY, SEAPORT, HC WAINWRIGHT.

Vernon Bernardino’s has documented 402 price targets and ratings displayed on 51 stocks. The coverage was on Healthcare, Basic Materials, Energy, Consumer Cyclical sectors.

Most recent stock forecast was given on NRXP, NRX Pharmaceuticals at 15-Oct-2025.

Wall Street Analyst Vernon Bernardino

Analyst best performing recommendations are on AEMD (AETHLON MEDICAL).
The best stock recommendation documented was for SAVA (CASSAVA SCIENCES) at 7/20/2021. The price target of $124 was fulfilled within 2 days with a profit of $33.17 (36.52%) receiving and performance score of 182.59.

Average potential price target upside

of $383.47 (94.58%) on CVM (CEL-SCI CORP).
of $376 (98.69%) on POAI (PREDICTIVE ONCOLOGY).
of $284.76 (96.94%) on EVOK (EVOKE PHARMA).

CVM CEL-SCI Corp NVAX Novavax RMED RA Medical Systems AIKI Aikido Pharma ARTL Artelo Biosciences AYTU Aytu BioScience DYAI Dyadic International ELDN Eledon Pharmaceuticals CYTK Cytokinetics MCRB Seres Therapeutics GOVX GeoVax Labs ABEO Abeona Therapeutics AVEO AVEO Pharmaceuticals CTXR Citius Pharmaceuticals EDSA Edesa Biotech GALT Galectin Therapeutics GMDA Gamida Cell Ltd NDRA ENDRA Life Sciences NRXP NRX Pharmaceuticals SAVA Cassava Sciences ACER Acer Therapeutics ARDS Aridis Pharmaceuticals CANF Can Fite Biopharma Ltd ADR FNCH Finch Therapeutics Group SENS Senseonics Holdings TFFP Tff Pharmaceuticals AEMD Aethlon Medical NVCN Neovasc EVOK Evoke Pharma CADL Candel Therapeutics CRDL Cardiol Therapeutics EXK Endeavour Silver Corp. HUMA Humacyte ENVB Enveric Biosciences PHIO Phio Pharmaceuticals Corp WINT Windtree Therapeutics EYPT Eyepoint Pharmaceuticals GERN Geron ICPT Intercept Pharmaceuticals MGEN Viridian Therapeutics MUX McEwen Mining RGLD Royal Gold VTVT vTv Therapeutics MBRX Moleculin Biotech TENX AR Antero Resources Corp AUPH Aurinia Pharmaceuticals CV GM General Motors Company POAI Predictive Oncology SA Seabridge Gold

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Tony Butler